267 related articles for article (PubMed ID: 19465708)
1. Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.
Sherman M
Cleve Clin J Med; 2009 May; 76 Suppl 3():S6-9. PubMed ID: 19465708
[TBL] [Abstract][Full Text] [Related]
2. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
[TBL] [Abstract][Full Text] [Related]
4. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
5. Halting the natural history of hepatitis B viral infection: a paradigm shift.
Perrillo RP; Jacobson IM
Semin Liver Dis; 2007 Aug; 27 Suppl 1():3-8. PubMed ID: 17701844
[TBL] [Abstract][Full Text] [Related]
6. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
7. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
[TBL] [Abstract][Full Text] [Related]
8. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
9. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Arakawa T; Fujimori M
J Med Virol; 2010 Apr; 82(4):539-45. PubMed ID: 20166172
[TBL] [Abstract][Full Text] [Related]
10. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
[TBL] [Abstract][Full Text] [Related]
11. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis.
Enriquez AD; Campbell MS; Reddy KR
Aliment Pharmacol Ther; 2007 Aug; 26(3):383-91. PubMed ID: 17635373
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of hepatocellular carcinoma in chronic hepatitis B with lamivudine?
Lim LY; Kowdley KV
Gastroenterology; 2005 Dec; 129(6):2120-2; discussion 2122. PubMed ID: 16344085
[No Abstract] [Full Text] [Related]
14. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.
Wu CF; Yu MW; Lin CL; Liu CJ; Shih WL; Tsai KS; Chen CJ
Carcinogenesis; 2008 Jan; 29(1):106-12. PubMed ID: 17999990
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
Khokhar A; Afdhal NH
Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
[TBL] [Abstract][Full Text] [Related]
16. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis B infection.
Omata M
N Engl J Med; 1998 Jul; 339(2):114-5. PubMed ID: 9654543
[No Abstract] [Full Text] [Related]
18. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
[TBL] [Abstract][Full Text] [Related]
19. Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy.
Lai MW; Huang SF; Hsu CW; Chang MH; Liaw YF; Yeh CT
Antivir Ther; 2009; 14(2):249-61. PubMed ID: 19430100
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
